Chris Maloof - Jun 15, 2022 Form 3 Insider Report for MeridianLink, Inc. (MLNK)

Role
President, Go To Market
Signature
/s/ Kayla Dailey, as Attorney-in-Fact
Stock symbol
MLNK
Transactions as of
Jun 15, 2022
Transactions value $
$0
Form type
3
Date filed
6/21/2022, 05:02 PM
Next filing
Jul 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MLNK Common Stock, par value $0.001 105K Jun 15, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MLNK Stock Option (option to buy) Jun 15, 2022 Common Stock, par value $0.001 135K $6.06 Direct F1
holding MLNK Stock Option (option to buy) Jun 15, 2022 Common Stock, par value $0.001 96.2K $26.00 Direct F2
holding MLNK Stock Option (option to buy) Jun 15, 2022 Common Stock, par value $0.001 49.5K $16.61 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 With respect to (i) 75,000 of the shares underlying the option, 75% of such shares vested upon the Issuer's achievement of a predetermined EBITDA metric on each of December 31, 2019, 2020, and 2021, and the remaining 25% of such shares are scheduled to vest based upon the Issuer's level of achievement of a predetermined EBITDA metric for 2022; and (ii) 60,000 of the shares underlying the option, 25% of such shares vested on October 14, 2020, and the remaining 75% of such shares vest in 36 equal monthly instalments thereafter, in each case subject to the reporting person's continued service through the applicable vesting date.
F2 25% of the shares underlying the option shall vest and become exercisable on July 27, 2022, and the remaining 75% of the shares underlying the option shall vest and become exercisable in 12 equal quarterly installments thereafter on the first day of the applicable month beginning at the start of the first calendar quarter following July 27, 2022, subject to the reporting person's continued service relationship with the Issuer through each applicable vesting date.
F3 25% of the shares underlying the option shall vest and become exercisable on May 2, 2023, and the remaining 75% of the shares underlying the option shall vest and become exercisable in 12 equal quarterly installments thereafter on the first day of the applicable month beginning at the start of the first calendar quarter following May 2, 2023, subject to the reporting person's continued service relationship with the Issuer through each applicable vesting date.

Remarks:

Exhibit 24 - Power of Attorney